Market Trends Toward New Normal in UROGEN PHARMA, Cimarex Energy, Boingo Wireless, TransCanada, EXTRACTION O&G, and ACADIA Pharmaceuticals — Emerging Consolidated Expectations, Analyst Ratings

Loading...
Loading...

NEW YORK, Oct. 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of UROGEN PHARMA URGN, Cimarex Energy Co XEC, Boingo Wireless, Inc. WIFI, TransCanada Corporation TRP, EXTRACTION O&G XOG, and ACADIA Pharmaceuticals Inc. ACAD, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

URGN DOWNLOAD: http://MarketSourceResearch.com/register/?so=URGN
XEC DOWNLOAD: http://MarketSourceResearch.com/register/?so=XEC
WIFI DOWNLOAD: http://MarketSourceResearch.com/register/?so=WIFI
TRP DOWNLOAD: http://MarketSourceResearch.com/register/?so=TRP
XOG DOWNLOAD: http://MarketSourceResearch.com/register/?so=XOG
ACAD DOWNLOAD: http://MarketSourceResearch.com/register/?so=ACAD

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Market Source Research, available for free download at the links above, examine UROGEN PHARMA URGN, Cimarex Energy Co XEC, Boingo Wireless, Inc. WIFI, TransCanada Corporation TRP, EXTRACTION O&G XOG, and ACADIA Pharmaceuticals Inc. ACAD on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 22nd, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

Loading...
Loading...

UROGEN PHARMA (URGN) REPORT OVERVIEW

UROGEN PHARMA's Recent Financial Performance

For the twelve months ended December 31st, 2017 vs December 31st, 2016, UROGEN PHARMA reported revenue of $8.16MM vs $17.53MM (down 53.46%) and analysts estimated basic earnings per share -$2.14 vs -$1.91. Analysts expect earnings to be released on November 13th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.02. The estimated EPS forecast for the next fiscal year is -$4.94 and is expected to report on March 21st, 2019.

To read the full UROGEN PHARMA (URGN) report, download it here: http://MarketSourceResearch.com/register/?so=URGN

-----------------------------------------

CIMAREX ENERGY CO (XEC) REPORT OVERVIEW

Cimarex Energy's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Cimarex Energy reported revenue of $556.27MM vs $456.45MM (up 21.87%) and analysts estimated basic earnings per share $1.48 vs $1.02 (up 45.10%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Cimarex Energy reported revenue of $1,918.25MM vs $1,257.35MM (up 52.56%) and analysts estimated basic earnings per share $5.19 vs -$4.38. Analysts expect earnings to be released on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was $1.09. The estimated EPS forecast for the next fiscal year is $7.95 and is expected to report on February 13th, 2019.

To read the full Cimarex Energy Co (XEC) report, download it here: http://MarketSourceResearch.com/register/?so=XEC

-----------------------------------------

BOINGO WIRELESS, INC. (WIFI) REPORT OVERVIEW

Boingo Wireless' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, Boingo Wireless reported revenue of $59.60MM vs $49.03MM (up 21.55%) and analysts estimated basic earnings per share $0.05 vs -$0.20. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Boingo Wireless reported revenue of $204.37MM vs $159.34MM (up 28.26%) and analysts estimated basic earnings per share -$0.49 vs -$0.72. Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was -$0.09. The estimated EPS forecast for the next fiscal year is -$0.25 and is expected to report on February 26th, 2019.

To read the full Boingo Wireless, Inc. (WIFI) report, download it here: http://MarketSourceResearch.com/register/?so=WIFI

-----------------------------------------

TRANSCANADA CORPORATION (TRP) REPORT OVERVIEW

TransCanada's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, TransCanada reported revenue of $2,476.13MM vs $2,392.48MM (up 3.50%) and basic earnings per share $0.68 vs $0.75 (down 9.19%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, TransCanada reported revenue of $10,374.56MM vs $9,443.78MM (up 9.86%) and analysts estimated basic earnings per share $2.65 vs $0.12 (up 2,093.06%). Analysts expect earnings to be released on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.56. The estimated EPS forecast for the next fiscal year is $2.76 and is expected to report on February 21st, 2019.

To read the full TransCanada Corporation (TRP) report, download it here: http://MarketSourceResearch.com/register/?so=TRP

-----------------------------------------

EXTRACTION O&G (XOG) REPORT OVERVIEW

EXTRACTION O&G's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, EXTRACTION O&G reported revenue of $260.20MM vs $119.77MM (up 117.25%) and analysts estimated basic earnings per share $0.03 vs $0.02 (up 50.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, EXTRACTION O&G reported revenue of $604.30MM vs $278.09MM (up 117.30%) and analysts estimated basic earnings per share -$0.35 vs -$1.54. Analysts expect earnings to be released on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.08. The estimated EPS forecast for the next fiscal year is $1.21 and is expected to report on February 26th, 2019.

To read the full EXTRACTION O&G (XOG) report, download it here: http://MarketSourceResearch.com/register/?so=XOG

-----------------------------------------

ACADIA PHARMACEUTICALS INC. (ACAD) REPORT OVERVIEW

ACADIA Pharmaceuticals' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, ACADIA Pharmaceuticals reported revenue of $57.06MM vs $30.48MM (up 87.25%) and analysts estimated basic earnings per share -$0.51 vs -$0.55. For the twelve months ended December 31st, 2017 vs December 31st, 2016, ACADIA Pharmaceuticals reported revenue of $124.90MM vs $17.33MM (up 620.68%) and analysts estimated basic earnings per share -$2.36 vs -$2.34. Analysts expect earnings to be released on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.53. The estimated EPS forecast for the next fiscal year is -$1.46 and is expected to report on February 26th, 2019.

To read the full ACADIA Pharmaceuticals Inc. (ACAD) report, download it here: http://MarketSourceResearch.com/register/?so=ACAD

-----------------------------------------

ABOUT MARKET SOURCE RESEARCH

Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.

REGISTERED MEMBER STATUS

Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com

© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Loading...
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...